Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_3
2
40%
Ph phase_2
1
20%
Ph phase_1
2
40%

Phase Distribution

2

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 32 (40.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_1

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)

NCT00961857
completedphase_2

Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)

NCT00758069
completedphase_3

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

NCT00086502
completedphase_3

Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)

NCT00106704
completedphase_1

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)

NCT00961480

Clinical Trials (5)

Showing 5 of 5 trials
NCT00961857Phase 1

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)

Completed
NCT00758069Phase 2

Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)

Completed
NCT00086502Phase 3

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

Completed
NCT00106704Phase 3

Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)

Completed
NCT00961480Phase 1

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5